What is Vergent Bioscience worth?
$75.0Mlast known valuation
Vergent Bioscience last raised $18.7M in its Early Stage VC (Oct 2025).
Free account
See the evidence behind this price
- ·Post-money valuations for all 5 rounds
- ·The complete investor list — 7 names
- ·Watchlist + deal alerts for Vergent Bioscience
Create free account
No card required
Funding history
5 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Oct 2025 | Early Stage VC | $18.7M | ▮ | ▮ |
| Feb 2025 | Seed Round | $3.8M | ▮ | ▮ |
| Aug 2022 | Early Stage VC | $21.5M | ▮ | ▮ |
| Nov 2021 | Seed Round | $1.2M | ▮ | ▮ |
| May 2018 | Early Stage VC | $11.9M | ▮ | ▮ |
How Vergent Bioscience's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Vergent Bioscience, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- What is Vergent Bioscience worth?
- Vergent Bioscience's last known valuation is $75.0M.
- How much has Vergent Bioscience raised?
- Vergent Bioscience has raised $56.4M in total funding across 5 recorded rounds.
- When did Vergent Bioscience last raise?
- Vergent Bioscience last raised in Oct 2025 (Early Stage VC), raising $18.7M.